The Global Pharmaceutical Excipients Market Growth Accelerated By Increased Demand For Modified Release Formulations
The pharmaceutical excipients
are chemicals formulated to serve pharmaceutical aid purposes alongside the
active pharmaceutical ingredients in drug compositions and formulations.
Pharmaceutical excipients are used to aid product formulation, processing,
stability and bioavailability. They improve functionality and end-user
experience. Pharmaceutical excipients help in enhancing drug solubility,
coating, binding and modifying drug release profiles among others.
The Global
Pharmaceutical Excipients Market Size is estimated to be valued at US$ 12.33 Bn in 2024 and is expected to
exhibit a CAGR of 6.9% over the
forecast period 2024 to 2031, as highlighted in a new report published by
Coherent Market Insights.
Market key trends:
Modified release formulations
such as extended and delayed release have gained popularity as they allow
modifying drug release profiles to achieve better pharmacokinetic and
pharmacodynamic drug profiles. Modified release formulations require
specialized excipients that can help in modifying drug release as per
requirement. Increased demand for modified release dosage forms from
pharmaceutical companies has accelerated demand for specialized excipients that
help in developing such formulations. This has emerged as a key trend in the
pharmaceutical excipients market driving increased research and development of
novel excipients suitable for modified release drug delivery.
Segment Analysis
The global pharmaceutical excipients market is dominated by the oral solid
dosage forms segment. Over 50% of all pharmaceutical formulations are oral
tablets and capsules, making it the largest sub-segment. The oral route is
convenient and cost-effective for various drugs. Further, oral solid dosage
forms provide stability, accuracy of dosage, and easy production which drives
their adoption rate over other formulations.
Key Takeaways
The global pharmaceutical excipients market is expected to witness high growth
over the forecast period of 2024 to 2031. Currently valued at US$ 12.33 billion in 2024, the market
is projected to reach over US$ 22
billion by 2031, registering a CAGR
of 6.9%.
Regional analysis
North America dominated the global market in 2024 and is expected to maintain
its leading position over the forecast years. The large presence of
pharmaceutical companies and medical research in the region supports market
growth. However, Asia Pacific is anticipated to be the fastest-growing regional
market owing to rising generic drug manufacturing and increasing investments in
pharmaceutical production in countries like India and China.
Key players
Key players operating in the pharmaceutical excipients market are Waters
Corporation, Agilent Technologies Inc., Bruker Corporation, SCIEX, Shimadzu
Corporation, Danaher, Thermo Fisher Scientific Inc., Shimadzu, and PerkinElmer
Inc. Major players are focused on expanding their production capacities and
capabilities through acquisitions and partnerships to strengthen their market
position globally.
Get
More Insights Here: https://www.newswirestats.com/pharmaceutical-excipients-market-trends-growth-and-regional-outlook-2023-2030/
Comments
Post a Comment